Pierre Canal

Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study.

M Forni, M C Malet-Martino, P Jaillais et al. · Journal of Clinical Oncology · 1992 · 334 citations

Prediction of Carboplatin Clearance From Standard Morphological and Biological Patient Characteristics

Étienne Chatelut, Pierre Canal, Vincent Brunner et al. · JNCI Journal of the National Cancer Institute · 1995 · 245 citations

Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function

Lionel Rostaing, Étienne Chatelut, J L Payen et al. · Journal of the American Society of Nephrology · 1998 · 172 citations · Full text

Normal Renal Function, Alphaifn Half-life, Immunology +17

Cellular determinants of oxaliplatin sensitivity in colon cancer cell lines

Stéphanie Arnould, Isabelle Hennebelle, Pierre Canal et al. · European Journal of Cancer · 2002 · 165 citations

Medicine, Colorectal Cancer, Pathology +6

Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trials.

Laurent P. Rivory, Marie‐Christine Haaz, Pierre Canal et al. · PubMed · 1997 · 140 citations

Plasma Kinetics, Chemoprevention Strategy, Pharmacokinetic Interrelationships +18